18 F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer

Matthijs H. van Gool,Tjeerd S. Aukema,Eva E. Schaake,Herman Rijna,Henk E. Codrington,Renato A. Valdés Olmos,Hendrik J. Teertstra,Renee van Pel,Sjaak A. Burgers,Harm van Tinteren,Houke M. Klomp

Annals of Surgical Oncology（2014）

引用 27|浏览11

暂无评分

摘要

To prospectively evaluate diagnostic computed tomography (CT) and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for identification of histopathologic response to neoadjuvant erlotinib, an epidermal growth factor receptor–tyrosine kinase inhibitor in patients with resectable non-small cell lung cancer (NSCLC).

查看译文

关键词

Epidermal Growth Factor Receptor,Erlotinib,Epidermal Growth Factor Receptor Mutation,Histopathologic Response,Diagnostic Compute Tomography

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要